secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001140361-23-054768
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech appoints Lars Boesgaard as CFO; Matthew Hill resigns effective Dec 1, 2023
--------------------------------------------------------------------------------

- CFO Matthew Hill resigned effective Dec 1, 2023 to pursue other opportunities; no disagreement with company.
- Lars Boesgaard appointed CFO effective Dec 4, 2023; brings 25+ years healthcare finance experience.
- Employment agreement: $420,000 annual salary, 40% performance bonus, 12-month severance, COBRA reimbursement.
- Boesgaard receives inducement option for 200,000 shares vesting over four years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036123054768/0001140361-23-054768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036123054768/ef20015466_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-054768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer